Clinical Trials Directory

Trials / Terminated

TerminatedNCT00347035

INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
Sponsor
Federal University of São Paulo · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers

Summary

Purpose: To evaluate the influence of the nonsteroidal anti-inflammatory indomethacin on the brimonidine intraocular pressure (IOP) lowering effect. Methods: A randomized double-masked study was carried out. Patients medicated with timolol maleate 0,5% and needed complementary medication were random allocated into two groups: (a) brimonidine tartarate 0,15% and indomethacin 1% or (b) brimonidine tartarate and placebo (balanced saline solution). If patient's both eyes were eligible, they were allocated to the same group. IOP was measured at two weeks, one month and two months after study beginning. The mean IOP of the eyes was used for analyzes, in the case of two eligible eyes. For statistical analyzes repeated measures analysis was used.

Conditions

Interventions

TypeNameDescription
DRUGbrimonidine

Timeline

First posted
2006-07-04
Last updated
2006-10-26

Source: ClinicalTrials.gov record NCT00347035. Inclusion in this directory is not an endorsement.